A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients
PRIMARY: To assess the effect of bovine anti-Cryptosporidium immunoglobulin (BACI) on the volume of diarrhea due to Cryptosporidium parvum in AIDS patients who have protracted Cryptosporidium enteritis.
SECONDARY: To assess changes in stool consistency and frequency, body weight, and safety in this patient population.
100 Clinical Results associated with Univax Biologics, Inc.
0 Patents (Medical) associated with Univax Biologics, Inc.
01 Jan 1995·Advances in experimental medicine and biologyQ4 · MEDICINE
Qualitative and Quantitative Immune Response to Bacterial Capsular Polysaccharides and Their Conjugates in Mouse and Man
Q4 · MEDICINE
Review
Author: Fattom, A
A review with 34 references discussing antigenicity and immunogenicity of capsular polysaccharides, and Staphylococcus aureus vaccines.
100 Deals associated with Univax Biologics, Inc.
100 Translational Medicine associated with Univax Biologics, Inc.